These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14638514)

  • 61. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
    Muñoz P; Marín M; Tornero P; Martín Rabadán P; Rodríguez-Creixéms M; Bouza E
    Clin Infect Dis; 2000 Dec; 31(6):1499-501. PubMed ID: 11096022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparative pathogenicity of Scedosporium species in murine model of systemic scedosporiosis.
    Elizondo-Zertuche M; Flores-Maldonado O; González GM; Becerril-Garcia M
    Braz J Microbiol; 2023 Sep; 54(3):1335-1340. PubMed ID: 37453029
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host.
    O'Doherty M; Hannan M; Fulcher T
    Orbit; 2005 Dec; 24(4):285-9. PubMed ID: 16354641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature.
    Farina C; Gotti E; Suter F; Goglio A
    Transplant Proc; 2006 Jun; 38(5):1333-5. PubMed ID: 16797295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
    Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.
    Kennedy B; Larcombe R; Chaptini C; Gordon DL
    J Antimicrob Chemother; 2015 Jul; 70(7):2171-3. PubMed ID: 25777322
    [No Abstract]   [Full Text] [Related]  

  • 72. Topical and oral voriconazole in the treatment of fungal keratitis.
    Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
    Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
    Kalkan Akçay E; Açıkgöz ZC; Can ME; Celikbilek N; Dereli Can G; Cağıl N
    Mikrobiyol Bul; 2013 Oct; 47(4):727-33. PubMed ID: 24237443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
    Morris AM
    Ann Intern Med; 2014 Jul; 161(2):JC8. PubMed ID: 25023274
    [No Abstract]   [Full Text] [Related]  

  • 76. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.
    Schaenman JM; DiGiulio DB; Mirels LF; McClenny NM; Berry GJ; Fothergill AW; Rinaldi MG; Montoya JG
    J Clin Microbiol; 2005 Feb; 43(2):973-7. PubMed ID: 15695722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Voriconazole and fungal keratitis: a report of two treatment failures.
    Giaconi JA; Marangon FB; Miller D; Alfonso EC
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
    Mazumder SA; Cleveland KO; Norwood J
    South Med J; 2010 Sep; 103(9):960-2. PubMed ID: 20689476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.